Satoshi Kano

13PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 02, 2026
Histological heterogeneity of SLFN11 expression and its association with response to carboplatin plus paclitaxel therapy in salivary gland cancer.

|Aug 03, 2026
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.

|Jul 31, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.

|Mar 08, 2026
Validation of the 9th Edition of the UICC TNM classification and the prognostic impact of nodal spread in salivary gland cancer.

Satoshi Kano, Takayoshi Suzuki, Nayuta Tsushima

|Sep 22, 2025
Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan.

Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi

|Mar 27, 2025
Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study.

Satoshi Kano, Takayoshi Suzuki, Daisuke Yoshida

Pageof 3

Frequent Collaborators

2 joint publications

Yuichiro Tada

2 joint publications

Toshitaka Nagao

1 joint publications

Yoshitaka Honma

1 joint publications

Nobuya Monden